← SynDRA
CAPADENOSON
SynDRA canonical compound SYN0037996 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ADORA1 |
| Mechanism of action | adenosine receptor agonist |
All known targets
Mechanisms of action (all sources)
- ADORA1 PARTIAL AGONIST
- Adenosine A1 receptor partial agonist
- adenosine receptor agonist
- ADORA1 AGONIST
Cross-references
Synonyms
- Bay-684986
- BAY-68-4986
- UNII-O519NVW73R
- O519NVW73R
- CHEMBL3235279
- BAY 68-4986
- 2-amino-6-[[[2-(4-chlorophenyl)-4-thiazolyl]methyl]thio]-4-[4-(2-hydroxyethoxy)phenyl]-3,5-Pyridinedicarbonitrile
- C25H18ClN5O2S2
- Capadenoson [INN]
- 2-amino-6-({(2-(4-chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-4-(4-(2-hydroxyethoxy)phenyl)pyridine-3,5-dicarbonitrile
- 2-amino-6-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-4-[4-(2-hydroxyethoxy)phenyl]pyridine-3,5-dicarbonitrile
- SCHEMBL174016
- Capadenoson;BAY 68-4986
- capadenosonum
- RefChem:123259
- DTXCID001397147
- MFCD09954113
- Capadenoson?
- CAPADENOSON [WHO-DD]
- orb1296185
- GTPL11221
- EX-A848
- CITWCLNVRIKQAF-UHFFFAOYSA-N
- GLXC-90353
- BAY684986
- BDBM50003646
- AKOS030632784
- BAY-684986
- CS-1228
- AC-35269
- AS-35054
- BC176871
- HY-14917
- DB-071852
- F811886
- BRD-K97025174-001-01-4
Look up CAPADENOSON in the interactive SynDRA portal →